STERIALS

A biotechnology company working on the development of double-sided fusion proteins as a new approach to immune regulation by designing structurally distinct biologics. In addition to developing treatments for ovarian cancer, squamous cell carcinoma of the skin, etc., the company is also collaborating with other companies to develop treatments for advanced solid tumors and lymphomas. Based in Delaware.